178 related articles for article (PubMed ID: 22361828)
1. Breadth of the CD4+ T cell response to Anaplasma marginale VirB9-1, VirB9-2 and VirB10 and MHC class II DR and DQ restriction elements.
Morse K; Norimine J; Hope JC; Brown WC
Immunogenetics; 2012 Jul; 64(7):507-23. PubMed ID: 22361828
[TBL] [Abstract][Full Text] [Related]
2. Intrahaplotype and interhaplotype pairing of bovine leukocyte antigen DQA and DQB molecules generate functional DQ molecules important for priming CD4(+) T-lymphocyte responses.
Norimine J; Brown WC
Immunogenetics; 2005 Nov; 57(10):750-62. PubMed ID: 16220347
[TBL] [Abstract][Full Text] [Related]
3. Association and evidence for linked recognition of type IV secretion system proteins VirB9-1, VirB9-2, and VirB10 in Anaplasma marginale.
Morse K; Norimine J; Palmer GH; Sutten EL; Baszler TV; Brown WC
Infect Immun; 2012 Jan; 80(1):215-27. PubMed ID: 22038917
[TBL] [Abstract][Full Text] [Related]
4. Anaplasma marginale type IV secretion system proteins VirB2, VirB7, VirB11, and VirD4 are immunogenic components of a protective bacterial membrane vaccine.
Sutten EL; Norimine J; Beare PA; Heinzen RA; Lopez JE; Morse K; Brayton KA; Gillespie JJ; Brown WC
Infect Immun; 2010 Mar; 78(3):1314-25. PubMed ID: 20065028
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers.
Norimine J; Han S; Brown WC
Immunogenetics; 2006 Sep; 58(9):726-39. PubMed ID: 16924490
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
[TBL] [Abstract][Full Text] [Related]
7. IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu.
Araújo FR; Costa CM; Ramos CA; Farias TA; Souza II; Melo ES; Elisei C; Rosinha GM; Soares CO; Fragoso SP; Fonseca AH
Mem Inst Oswaldo Cruz; 2008 Mar; 103(2):186-90. PubMed ID: 18425271
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.
Brown WC; McGuire TC; Mwangi W; Kegerreis KA; Macmillan H; Lewin HA; Palmer GH
Infect Immun; 2002 Oct; 70(10):5521-32. PubMed ID: 12228278
[TBL] [Abstract][Full Text] [Related]
9. Duplicated DQ haplotypes increase the complexity of restriction element usage in cattle.
Glass EJ; Oliver RA; Russell GC
J Immunol; 2000 Jul; 165(1):134-8. PubMed ID: 10861045
[TBL] [Abstract][Full Text] [Related]
10. High-throughput identification of T-lymphocyte antigens from Anaplasma marginale expressed using in vitro transcription and translation.
Lopez JE; Beare PA; Heinzen RA; Norimine J; Lahmers KK; Palmer GH; Brown WC
J Immunol Methods; 2008 Mar; 332(1-2):129-41. PubMed ID: 18243240
[TBL] [Abstract][Full Text] [Related]
11. Selection of T-cell epitopes from foot-and-mouth disease virus reflects the binding affinity to different cattle MHC class II molecules.
Haghparast A; Wauben MH; Grosfeld-Stulemeyer MC; van Kooten P; Hensen EJ
Immunogenetics; 2000 Jul; 51(8-9):733-42. PubMed ID: 10941845
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
13. A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.
Sarli M; Novoa MB; Mazzucco MN; Signorini ML; Echaide IE; de Echaide ST; Primo ME
PLoS One; 2020; 15(2):e0229301. PubMed ID: 32084216
[TBL] [Abstract][Full Text] [Related]
14. Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses.
Brown WC; McGuire TC; Zhu D; Lewin HA; Sosnow J; Palmer GH
J Immunol; 2001 Jan; 166(2):1114-24. PubMed ID: 11145692
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-Based Delivery of Anaplasma marginale Membrane Proteins; VirB9-1 and VirB10 Produced in the Pichia pastoris Expression System.
Zhang B; Cavallaro AS; Mody KT; Zhang J; Deringer JR; Brown WC; Mahony TJ; Yu C; Mitter N
Nanomaterials (Basel); 2016 Nov; 6(11):. PubMed ID: 28335329
[TBL] [Abstract][Full Text] [Related]
16. Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules.
Mustafa AS; Shaban FA; Al-Attiyah R; Abal AT; El-Shamy AM; Andersen P; Oftung F
Scand J Immunol; 2003 Feb; 57(2):125-34. PubMed ID: 12588658
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.
Zhao L; Mahony D; Cavallaro AS; Zhang B; Zhang J; Deringer JR; Zhao CX; Brown WC; Yu C; Mitter N; Middelberg AP
PLoS One; 2016; 11(4):e0154295. PubMed ID: 27115492
[TBL] [Abstract][Full Text] [Related]
18. Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale.
Abbott JR; Palmer GH; Kegerreis KA; Hetrick PF; Howard CJ; Hope JC; Brown WC
J Immunol; 2005 Jun; 174(11):6702-15. PubMed ID: 15905510
[TBL] [Abstract][Full Text] [Related]
19. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
[TBL] [Abstract][Full Text] [Related]
20. A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice.
Chen Z; Dudek N; Wijburg O; Strugnell R; Brown L; Deliyannis G; Jackson D; Koentgen F; Gordon T; McCluskey J
J Immunol; 2002 Mar; 168(6):3050-6. PubMed ID: 11884478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
